SYMPTOMATIC IMPROVEMENT OBSERVED WITHIN 2 DAYS OF ETRASIMOD INDUCTION THERAPY: RESULTS FROM ELEVATE UC 52 AND ELEVATE UC 12 STUDIES IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky  1     Severine Vermeire  2     María Chaparro  3, 4, 5     Peter Irving  6     Lauren Bartolome  7     John C. Woolcott  8     Christopher J. Rabbat     Wenjin Wang     Martina Goetsch  9     Joana Torres  10, 11, 12     Remo Panaccione  13    
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 University Hospitals Leuven, Leuven, Belgium
3 Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS Princesa), Madrid, Spain
4 Universidad Autónoma de Madrid (UAM), Madrid, Spain
5 Centro de Investigacíon Biomédica en Red de Enfermedades Hepáticas y Digestivas
6 Guy´s and St Thomas´ NHS Foundation Trust, London, United Kingdom
7 Pfizer Inc, New York, United States
8 Pfizer Inc, Collegeville, United States
9 Pfizer AG, Zürich, Switzerland
10 Hospital Beatriz Ângelo, Loures, Portugal
11 Hospital da Luz, Lisbon, Portugal
12 Universidade de Lisboa, Lisbon, Portugal
13 University of Calgary, Calgary, Canada

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing